RESEARCH
LATEST
FULL LIST
-
Vital3D Targets Pet Care Market as Strategic Entry Point to Bioprinted Human Organs
Commercial Focus Begins with Veterinary Wound Care Lithuanian startup Vital3D is positioning itself at the forefront of bioprinted organ development, with a projected timeline of 10 to 15 years for human applications. As a first step toward that goal, the company is entering the market with VitalHeal, a 3D-bioprinted wound patch for pets — beginning…
-
Collagen-Based 3D Bioprinting Offers Fully Perfusable Gel Based Organ-On-Chips
A team of bioengineers at Carnegie Mellon University has unveiled a new tissue engineering platform. The study, published in Science Advances, introduces CHIPS (Collagen-based High-resolution Internally Perfusable Scaffolds), a new class of biological, perfusable 3D-printed tissue constructs, and VAPOR, a customizable perfusion bioreactor designed to support them. What’s the Technology? The platform uses an improved…
-
Quris Technologies Demonstrates Liver-Driven Brain Toxicity in New Multi-Organ Model
A recent study by Quris Technologies highlights how drug metabolism in the liver can significantly alter a compound’s neurotoxicity, providing new insights into limitations of traditional drug testing methods. Published in Biomedicine & Pharmacotherapy, the findings suggest a greater role for multi-organ, human-relevant testing platforms in preclinical development. Using a proprietary platform called BioAI, Quris…
-
Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs
Xylyx Bio, Inc., a regenerative medicine company, today announced that it has received $1,000,000 from the Richard M. Bartlett Jr. Memorial Foundation and an additional $125,000 from the Ilene Beal Foundation and Margaret Stewart Lindsay Foundation. These funds will accelerate the translational development of Xylyx’s groundbreaking bioengineered human lung grafts, which aim to drastically increase…
-
EU-Funded micro2MACRO Project Aims to Push Cartilage Tissue Regeneration with Bioprinting
Teltow, February 5, 2025 – A new European initiative is set to push the boundaries of tissue regeneration and bioprinting. The micro2MACRO (m2M) project, launched in December 2024, is an EU-funded effort that aims to develop a cutting-edge bioprinting platform capable of generating personalized tissue grafts for medical applications. The project brings together leading academic…
-
Auxilium Biotechnologies Achieves Bioprinting Milestone Aboard the ISS
Auxilium Biotechnologies successfully deployed its 3D bioprinter aboard the International Space Station (ISS). This achievement marks the an instance of implantable medical devices being printed in space, paving further way for advanced medical solutions both on Earth and in future space missions. Printing Medical Devices in Microgravity Auxilium Biotechnologies has successfully 3D bioprinted perfusable vasculature,…
-
Handheld Bioprinting with Kombucha-Based Bioink
The world of bioprinting is evolving rapidly, and a recent study published in the International Journal of Biological Macromolecules from Dr. Insup Noh Lab at Seoul Tech introduces a novel approach that could revolutionize the field: a handheld bioprinting system using kombucha-derived nanocellulose bioink. This innovative method offers promise for regenerating irregular and multilayered tissue defects…
-
Time Code: Improved Printing Code for 3D Bioprinting
Introduction The field of bioprinting has made strides in recent years. However, despite advances in multifunctional 3D printheads, the standard G-Code used for print path execution presents a significant limitation: it forces interruptions in the print process whenever auxiliary controls, such as material switching or UV curing, are required. This leads to defects, reduced precision,…
-
MEDELLAPRO®: Endotoxin-Controlled Bioprinting Materials
The bioprinting industry is advancing, with new materials playing a critical role in pushing the boundaries of regenerative medicine, tissue engineering, and biomedical innovation. One of the latest breakthroughs comes from GELITA, which has introduced MEDELLAPRO®, an endotoxin-controlled gelatin designed specifically for 3D bioprinting, cell culturing, and medical implants. This high-purity biomaterial offers safety, biocompatibility,…
-
Further Unlocking the Potential of 4D Bioprinting for Heart Tissue Engineering
4D Bioprinting: Not a New Concept, But What Makes This Study Unique? The concept of 4D bioprinting—creating printed constructs that transform over time—has been around for over a decade. However, recent work, in Advanced Functional Materials out of Andrew Daly’s lab, are pushing the boundaries of this technology by integrating cell biology, computational modeling, and…
Subscribe
Enter your email below to receive updates.
The Business of Biofabrication 